Schweiger V, Sorella S, Palmisano L et al (2025) Acetyl-L-Carnitine as an add-on treatment in fibromyalgia syndrome: a retrospective analysis on 183 patients, according to the generalized linear mixed model for longitudinal data
Anemia is a major complication that affects the patients quality of life (QoL) which worsens with declining renal function
Baseline MELD-3 AUC = 0.650) suggests that disease trajectory during treatment, rather than treatment itself, is the dominant factor determining outcomes
After 18 days (D24) of L-carnitine intervention, the four groups of mice were sacrificed using 4% isoflurane, then blood and tissue samples were collected and evaluated
The synergy between these compounds addresses the primary limitation of GLP-1 medications: losing muscle alongside fat
Anti-inflammatory and Antioxidant Action Chronic inflammation and oxidative stress contribute to accelerated hair loss